These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 18955579)
1. Podocalyxin expression in undifferentiated thyroid carcinomas. Yasuoka H; Tsujimoto M; Hirokawa M; Tori M; Nakahara M; Miyauchi A; Kodama R; Sanke T; Nakamura Y J Clin Pathol; 2008 Nov; 61(11):1228-9. PubMed ID: 18955579 [No Abstract] [Full Text] [Related]
2. S100A9 expression is significantly linked to dedifferentiation of thyroid carcinoma. Ito Y; Arai K; Ryushi ; Nozawa ; Yoshida H; Tomoda C; Uruno T; Miya A; Kobayashi K; Matsuzuka F; Kuma K; Kakudo K; Miyauchi A Pathol Res Pract; 2005; 201(8-9):551-6. PubMed ID: 16259107 [TBL] [Abstract][Full Text] [Related]
3. Expression of p27kip1 and Ki-67 in benign and malignant thyroid tumors. Erickson LA; Jin L; Wollan PC; Thompson GB; van Heerden J; Lloyd RV Mod Pathol; 1998 Feb; 11(2):169-74. PubMed ID: 9504687 [TBL] [Abstract][Full Text] [Related]
4. Met protein and hepatocyte growth factor (HGF) in papillary carcinoma of the thyroid: evidence for a pathogenetic role in tumourigenesis. Ruco LP; Stoppacciaro A; Ballarini F; Prat M; Scarpino S J Pathol; 2001 May; 194(1):4-8. PubMed ID: 11329134 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic significance of CK19, RET, galectin-3 and HBME-1 expression for papillary thyroid carcinoma. Zhu X; Sun T; Lu H; Zhou X; Lu Y; Cai X; Zhu X J Clin Pathol; 2010 Sep; 63(9):786-9. PubMed ID: 20644217 [TBL] [Abstract][Full Text] [Related]
6. DUSP6/MKP3 is overexpressed in papillary and poorly differentiated thyroid carcinoma and contributes to neoplastic properties of thyroid cancer cells. Degl'Innocenti D; Romeo P; Tarantino E; Sensi M; Cassinelli G; Catalano V; Lanzi C; Perrone F; Pilotti S; Seregni E; Pierotti MA; Greco A; Borrello MG Endocr Relat Cancer; 2013 Feb; 20(1):23-37. PubMed ID: 23132790 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of 16 cellular tumor markers for metastatic thyroid cancer: an immunohistochemical study. Liang H; Zhong Y; Luo Z; Huang Y; Lin H; Zhan S; Xie K; Li QQ Anticancer Res; 2011 Oct; 31(10):3433-40. PubMed ID: 21965758 [TBL] [Abstract][Full Text] [Related]
8. Expression profile of endothelin 1 and its receptor endothelin receptor A in papillary thyroid carcinoma and their correlations with clinicopathologic characteristics. Irani S; Salajegheh A; Gopalan V; Smith RA; Lam AK Ann Diagn Pathol; 2014 Apr; 18(2):43-8. PubMed ID: 24332749 [TBL] [Abstract][Full Text] [Related]
9. Possible relation of osteopontin to development of psammoma bodies in human papillary thyroid cancer. Tunio GM; Hirota S; Nomura S; Kitamura Y Arch Pathol Lab Med; 1998 Dec; 122(12):1087-90. PubMed ID: 9870857 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical study of type-1 blood antigen expressions in thyroid tumors: the significance for papillary carcinomas. Kamoshida S; Ogane N; Yasuda M; Muramatsu T; Bessho T; Kajiwara H; Osamura RY Mod Pathol; 2000 Jul; 13(7):736-41. PubMed ID: 10912932 [TBL] [Abstract][Full Text] [Related]
11. The expression and role of serum response factor in papillary carcinoma of the thyroid. Kim HJ; Kim KR; Park HS; Jang KY; Chung MJ; Shong M; Moon WS Int J Oncol; 2009 Jul; 35(1):49-55. PubMed ID: 19513551 [TBL] [Abstract][Full Text] [Related]
12. Expression of the melanoma-associated antigen is associated with progression of human thyroid cancer. Cheng S; Liu W; Mercado M; Ezzat S; Asa SL Endocr Relat Cancer; 2009 Jun; 16(2):455-66. PubMed ID: 19261683 [TBL] [Abstract][Full Text] [Related]
13. [The significance of p63 expression in thyroid neoplasm]. Qian M; Wang J Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2008 Oct; 22(19):888-90, 893. PubMed ID: 19160863 [TBL] [Abstract][Full Text] [Related]
14. Differential expression of the components of the plasminogen activating system in human thyroid tumour derived cell lines and papillary carcinomas. Ulisse S; Baldini E; Toller M; Marchioni E; Giacomelli L; De Antoni E; Ferretti E; Marzullo A; Graziano FM; Trimboli P; Biordi L; Curcio F; Gulino A; Ambesi-Impiombato FS; D'Armiento M Eur J Cancer; 2006 Oct; 42(15):2631-8. PubMed ID: 16928445 [TBL] [Abstract][Full Text] [Related]
15. [The morphological and immunohistochemical features and malignancy potential of a hyalinizing trabecular tumor of the thyroid]. Abrosimov AIu; Dvinskikh NIu; Makanin MA; mal'kov PG; Grinevich VN Arkh Patol; 2009; 71(6):36-9. PubMed ID: 20131505 [TBL] [Abstract][Full Text] [Related]
16. Bag-1 expression in thyroid neoplasm: its correlation with Bcl-2 expression and carcinoma dedifferentiation. Ito Y; Yoshida H; Nakano K; Takamura Y; Miya A; Kobayashi K; Yokozawa T; Matsuzuka F; Matsuura N; Kakudo K; Kuma K; Miyauchi A Anticancer Res; 2003; 23(1B):569-76. PubMed ID: 12680148 [TBL] [Abstract][Full Text] [Related]
17. Expression of cell-cycle regulators (cyclin D1, cyclin E, p27kip1, p57kip2) in papillary thyroid carcinoma. Lee SH; Lee JK; Jin SM; Lee KC; Sohn JH; Chae SW; Kim DH Otolaryngol Head Neck Surg; 2010 Mar; 142(3):332-7. PubMed ID: 20172376 [TBL] [Abstract][Full Text] [Related]